ID   UISO-BCA-2
AC   CVCL_D250
SY   UISO BCA 2; University of Illinois Surgical Oncology-Breast CArcinoma-2
DR   Wikidata; Q54990241
RX   DOI=10.1016/0165-4608(96)85256-3;
RX   PubMed=1377894;
CC   Doubling time: 56.0 +/- 5.0 hours (PubMed=1377894).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 13
//
RX   DOI=10.1016/0165-4608(96)85256-3;
RA   Mehta R.R., Hicken T.J., Green A.D., Graves J.M., Das Gupta T.K.;
RT   "Cytogenetic and molecular variations in newly established metastatic
RT   and non-metastatic breast cancer cell lines.";
RL   Cancer Genet. Cytogenet. 84:142.A7-142.A7(1995).
//
RX   PubMed=1377894;
RA   Mehta R.R., Bratescu L., Graves J.M., Hart G.D., Shilkaitis A.,
RA   Green A., Beattie C.W., Das Gupta T.K.;
RT   "Human breast carcinoma cell lines: ultrastructural, genotypic, and
RT   immunocytochemical characterization.";
RL   Anticancer Res. 12:683-692(1992).
//